Abstract

This review concentrates on tumours that are anatomically localised in head and neck regions. Brain cancers and head and neck cancers together account for more than 873,000 cases annually worldwide, with an increasing incidence each year. With poor survival rates at late stages, brain and head and neck cancers represent serious conditions. Carcinogenesis is a multi-step process and the role of infectious agents in this progression has not been fully identified. A major problem with such research is that the role of many infectious agents may be underestimated due to the lack of or inconsistency in experimental data obtained globally. In the case of brain cancer, no infection has been accepted as directly oncogenic, although a number of viruses and parasites are associated with the malignancy. Our analysis of the literature showed the presence of human cytomegalovirus (HCMV) in distinct types of brain tumour, namely glioblastoma multiforme (GBM) and medulloblastoma. In particular, there are reports of viral protein in up to 100% of GBM specimens. Several epidemiological studies reported associations of brain cancer and toxoplasmosis seropositivity. In head and neck cancers, there is a distinct correlation between Epstein-Barr virus (EBV) and nasopharyngeal carcinoma (NPC). Considering that almost every undifferentiated NPC is EBV-positive, virus titer levels can be measured to screen high-risk populations. In addition there is an apparent association between human papilloma virus (HPV) and head and neck squamous cell carcinoma (HNSCC); specifically, 26% of HNSCCs are positive for HPV. HPV type 16 was the most common type detected in HNSCCs (90%) and its dominance is even greater than that reported in cervical carcinoma. Although there are many studies showing an association of infectious agents with cancer, with various levels of involvement and either a direct or indirect causative effect, there is a scarcity of articles covering the role of infection in carcinogenesis of brain and head and neck cancers. We review recent studies on the infectious origin of these cancers and present our current understanding of carcinogenic mechanisms, thereby providing possible novel approaches to cancer treatment.

Highlights

  • More than 237,000 people are diagnosed with brain cancer annually [1]

  • Most head and neck cancers are squamous cell carcinomas progressing from the thin epithelial lining of the head and neck tissue

  • Concluding notes: Can carcinogenesis be inhibited by treatment against infections? Various studies have shown that anti-viral and anti-bacterial drug treatments have a favourable effect on prognosis through prevention of tumorigenesis

Read more

Summary

Introduction

More than 237,000 people are diagnosed with brain cancer annually [1]. Central nervous system (CNS) tumours are classified by the World Health Organization according to histological pattern, cell behaviour, and cytogenetics. Abbreviations CBP/p300: CREB binding protein/p300; 0CMV: Cytomegalovirus; COX-2: Cyclooxygenase 2; SV40: Simian virus 40; BKV: BK virus; JCV: John Cunningham virus; EBER: Epstein-Barr virus-encoded small RNA; EBNA: Epstein-Barr nuclear antigens; EBV: Epstein-Barr virus; EDNRB: Endothelin receptor type B; GBM: Glioblastoma multiforme; HCMV: Human cytomegalovirus; HNSCC: Head and neck squamous cell carcinoma; HPV: Human papilloma virus; IARC: International Agency for Research on Cancer; IgA: Immunoglobulin A; IL: Interleukin; LMP: Latent membrane proteins; MHC: Major histocompatibility complex; NPC: Nasopharyngeal carcinoma; OSCC: Oral squamous cell carcinoma; KS: Kaposi’s sarcoma; PGE2: Prostaglandin E2; PI3K/AKT: Phosphatidylinositol3-kinase and protein kinase B; RASSF1A: Ras association domain family 1A; MAPK: Mitogen-activated protein kinase; β-FGF: β-fibroblast growth factor; PDGF: Platelet-derived growth factor; VEGF: Vascular endothelial growth factor; Tat: Trans-activator of transcription.

39. Brennan B
47. Lasisi OA
65. Lehrer S
71. Foreman KE
74. Kocazeybek B
77. Lax AJ: Opinion
81. Schwarz TF
84. Melief CJ
Findings
87. Volpi A
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call